Evidence map›Paper›PMID 36822479›Full record

ArticleJournal of hepatology2023

Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltransferase 1a-mediated fatty acid oxidation.

Robert N Helsley, Se-Hyung Park, Hemendra J Vekaria, Patrick G Sullivan, Lindsey R Conroy, Ramon C Sun, María Del Mar Romero, Laura Herrero, Joanna Bons, Christina D King and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Robert N HelsleyDepartment of Pediatrics and Gastroenterology, University of Kentucky, Lexington, KY, USA; Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA; Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
Se-Hyung ParkDepartment of Pediatrics and Gastroenterology, University of Kentucky, Lexington, KY, USA; Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
Hemendra J VekariaSpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY, USA.
Patrick G SullivanSpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY, USA.
Lindsey R ConroyDepartment of Neuroscience, University of Kentucky, Lexington, KY, USA.
Ramon C SunDepartment of Neuroscience, University of Kentucky, Lexington, KY, USA; Department of Biochemistry & Molecular Biology, University of Florida, Gainesville, FL, USA; Center for Advanced Spatial Biomolecule Research, University of Florida, Gainesville, FL, USA.
María Del Mar RomeroSchool of Pharmacy, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, 08028, Spain; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain.
Laura HerreroSchool of Pharmacy, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, 08028, Spain; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain.
Joanna BonsChemistry & Mass Spectrometry, Buck Institute for Research on Aging, Novato, CA, USA.
Christina D KingChemistry & Mass Spectrometry, Buck Institute for Research on Aging, Novato, CA, USA.
Jacob RoseChemistry & Mass Spectrometry, Buck Institute for Research on Aging, Novato, CA, USA.
Jesse G MeyerChemistry & Mass Spectrometry, Buck Institute for Research on Aging, Novato, CA, USA; Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Birgit SchillingChemistry & Mass Spectrometry, Buck Institute for Research on Aging, Novato, CA, USA.
C Ronald KahnJoslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA, USA.
Samir SofticDepartment of Pediatrics and Gastroenterology, University of Kentucky, Lexington, KY, USA; Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA; Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA, USA. Electronic address: samir.softic@uky.edu.
University of Kentucky · USBuck Institute for Research on Aging · USInstituto de Salud Carlos III · ESJoslin Diabetes Center · USCedars-Sinai Medical Center · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Pilot Projects ProgramP30GM127211 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2018 to 2022
$5.7M
Interdisciplinary Research Training in Cancer BiologyT32CA165990 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers, KATHLEEN L. O'CONNOR · 2013 to 2026
$3.2M
Alterations in Post-Receptor Insulin Signaling in Diabetes and Insulin ResistanceR01DK128429 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 2021 to 2025
$2.9M
Interaction between genes, environment, the microbiome and metabolome in type 2 diabetes and metabolic syndromeR01DK121967 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 2020 to 2024
$2.7M
Orbitrap Fusion Lumos ETD with FAIMS ProS10OD028654 · OD · BUCK INSTITUTE FOR RESEARCH ON AGING · PI SCHILLING, BIRGIT · 2020 to 2020
$1.1M
Elucidating Molecular Mechanisms Linking Fructose to Cholesterol MetabolismK01DK128022 · NIDDK · UNIVERSITY OF KENTUCKY · PI Robert Nathaniel Helsley · 2022 to 2026
$647k
NCATS NIH HHS UL1 TR001998NCI NIH HHS T32 CA165990NICHD NIH HHS K12 HD000850NIDDK NIH HHS K01 DK128022NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK128429NIGMS NIH HHS P30 GM127211NIH HHS S10 OD028654
6 · The paper itself

Abstract

BACKGROUND &

aimsThe consumption of sugar and a high-fat diet (HFD) promotes the development of obesity and metabolic dysfunction. Despite their well-known synergy, the mechanisms by which sugar worsens the outcomes associated with a HFD are largely elusive.

methodsSix-week-old, male, C57Bl/6 J mice were fed either chow or a HFD and were provided with regular, fructose- or glucose-sweetened water. Moreover, cultured AML12 hepatocytes were engineered to overexpress ketohexokinase-C (KHK-C) using a lentivirus vector, while CRISPR-Cas9 was used to knockdown CPT1α. The cell culture experiments were complemented with in vivo studies using mice with hepatic overexpression of KHK-C and in mice with liver-specific CPT1α knockout. We used comprehensive metabolomics, electron microscopy, mitochondrial substrate phenotyping, proteomics and acetylome analysis to investigate underlying mechanisms.

resultsFructose supplementation in mice fed normal chow and fructose or glucose supplementation in mice fed a HFD increase KHK-C, an enzyme that catalyzes the first step of fructolysis. Elevated KHK-C is associated with an increase in lipogenic proteins, such as ACLY, without affecting their mRNA expression. An increase in KHK-C also correlates with acetylation of CPT1α at K508, and lower CPT1α protein in vivo. In vitro, KHK-C overexpression lowers CPT1α and increases triglyceride accumulation. The effects of KHK-C are, in part, replicated by a knockdown of CPT1α. An increase in KHK-C correlates negatively with CPT1α protein levels in mice fed sugar and a HFD, but also in genetically obese db/db and lipodystrophic FIRKO mice. Mechanistically, overexpression of KHK-C in vitro increases global protein acetylation and decreases levels of the major cytoplasmic deacetylase, SIRT2.

conclusionsKHK-C-induced acetylation is a novel mechanism by which dietary fructose augments lipogenesis and decreases fatty acid oxidation to promote the development of metabolic complications. IMPACT AND IMPLICATIONS: Fructose is a highly lipogenic nutrient whose negative consequences have been largely attributed to increased de novo lipogenesis. Herein, we show that fructose upregulates ketohexokinase, which in turn modifies global protein acetylation, including acetylation of CPT1a, to decrease fatty acid oxidation. Our findings broaden the impact of dietary sugar beyond its lipogenic role and have implications on drug development aimed at reducing the harmful effects attributed to sugar metabolism.

Indexed as

Carnitine O-PalmitoyltransferaseLiverAcetylationAnimalsDiet, High-FatFatty AcidsFructokinasesFructoseGlucoseMaleMiceObesityCarnitine O-PalmitoyltransferaseFatty AcidsFructokinasesFructoseGlucosecarnitine palmitoyltransferase 1afatty acid oxidationFructoseKetohexokinasemass spectrometryNonalcoholic fatty liver diseaseSIRT2

Identifiers

PMID36822479
PMCPMC10679901
OpenAlexW4321438807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.